Christoffer Lorenzen

Christoffer Lorenzen is the current CEO at Karo Pharma. Christoffer has also previously served as a Board Member for HAMLET PROTEIN and as Executive Vice President for Chr. Hansen Holding A/S. In their most recent role at Karo Pharma, Christoffer has been instrumental in developing the company's strategy and growth plan. Prior to joining Karo Pharma, they spent 15 years in the pharmaceutical industry, first with H. Lundbeck A/S and then with Chr. Hansen Holding A/S. During their time at Chr. Hansen, they were responsible for the Food Cultures and Enzymes Division, which is the largest business within the company. Christoffer has also served on several Boards and Steering Committees, including the Digital Steerco and the Innovation Steering Group (Food) at Chr. Hansen. Christoffer has a wealth of experience in developing and executing growth strategies, as well as a proven track record in building successful businesses.

Christoffer Lorenzen has a background in business administration and economics, having completed a Master's degree at Copenhagen Business School as well as an exchange program at emlyon business school. Christoffer also has a BSc from Copenhagen Business School and Pacific Lutheran University. Prior to joining Singularity University, they were completing an executive programme at INSEAD.

Some individuals on their team include Jon Johnsson - CFO, Jonathan Kimber - VP, Operations, and Sofia Pedersen - VP, Scientific Affairs.